|
市場調査レポート
商品コード
1456852
急性呼吸窮迫症候群治療の世界市場 2024-2028Global Acute Respiratory Distress Syndrome Treatment Market 2024-2028 |
||||||
● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。 詳細はお問い合わせください。 |
急性呼吸窮迫症候群治療の世界市場 2024-2028 |
出版日: 2024年03月15日
発行: TechNavio
ページ情報: 英文 161 Pages
納期: 即納可能
|
急性呼吸窮迫症候群治療市場は2023-2028年に12億2,000万米ドル、予測期間中のCAGRは6.9%で成長すると予測されます。
当レポートでは、急性呼吸窮迫症候群治療市場の全体的な分析、市場規模・予測、動向、成長促進要因、課題、約25のベンダーを網羅したベンダー分析などを掲載しています。
現在の市場シナリオ、最新動向と促進要因、市場環境全体に関する最新分析を提供しています。市場は、肺保護換気戦略への注目の高まり、精密医療とバイオマーカー研究の進歩、エクモ療法の利用増加などが牽引しています。
市場範囲 | |
---|---|
基準年 | 2024 |
終了年 | 2028 |
予測期間 | 2024-2028 |
成長モメンタム | 加速 |
前年比2024年 | 6.2% |
CAGR | 6.9% |
増分額 | 12億2,000万米ドル |
本調査では、今後数年間の急性呼吸窮迫症候群治療市場の成長を牽引する主な要因の一つとして、膠原病に対する免疫調節療法への関心の高まりを挙げています。また、膠原病治療薬の再利用戦略の出現や、膠原病の多剤併用支持療法に対する認識の高まりも、市場の大きな需要につながるであろう。
Exhibits:
The acute respiratory distress syndrome treatment market is forecasted to grow by USD 1.22 bn during 2023-2028, accelerating at a CAGR of 6.9% during the forecast period. The report on the acute respiratory distress syndrome treatment market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by growing focus on lung-protective ventilation strategies, advances in precision medicine and biomarker research, and increasing utilization of ecmo therapy.
Technavio's acute respiratory distress syndrome treatment market is segmented as below:
Market Scope | |
---|---|
Base Year | 2024 |
End Year | 2028 |
Series Year | 2024-2028 |
Growth Momentum | Accelerate |
YOY 2024 | 6.2% |
CAGR | 6.9% |
Incremental Value | $1.22bn |
By Distribution Channel
By Route Of Administration
By Geographical Landscape
This study identifies the growing interest in immunomodulatory therapies for ards as one of the prime reasons driving the acute respiratory distress syndrome treatment market growth during the next few years. Also, emergence of ards drug repurposing strategies and increasing recognition of multimodal supportive care for ards will lead to sizable demand in the market.
The report on the acute respiratory distress syndrome treatment market covers the following areas:
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading acute respiratory distress syndrome treatment market vendors that include Air Liquide SA, Athersys Inc., Boston Scientific Corporation, Dragerwerk AG and Co. KGaA, Getinge AB, Koninklijke Philips N.V., LivaNova PLC, Medtronic, Nihon Kohden Corp., SCHILLER AG, Sleepnet Corp., Stryker Corp., Vyaire Medical Inc., Smiths Group Plc, ResMed Inc., Hamilton Medical AG, GE Healthcare Technologies Inc., Fisher and Paykel Healthcare Corp. Ltd., Edesa Biotech Inc., and APEPTICO Forschung und Entwicklung GmbH. Also, the acute respiratory distress syndrome treatment market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.